new proteomics strategies for studying alzheimer's and

44
New Proteomics Strategies for Studying Alzheimer's and Related Dementias MacCoss, Hoofnagle, and Montine Labs

Upload: others

Post on 04-Nov-2021

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: New Proteomics Strategies for Studying Alzheimer's and

New Proteomics Strategies for Studying Alzheimer's and

Related DementiasMacCoss, Hoofnagle, and Montine Labs

Page 2: New Proteomics Strategies for Studying Alzheimer's and

Projects Related to Signatures of AD and Related Dementias

• Neuropathological assessment of resilience in post-mortem braino Can we have a molecular assay that can distinguish between:

Different AD genetic risk Associated co-morbities Resilience to AD neuropathologic change

o Can we develop a proteomics assay to use as a replacement of traditional histopathological assessment.

• Cerebral spinal fluid assay that can reflect brain pathophysiologyo Can we expand beyond the use of CSF Aβ42, tau, and P181-tau, and PET imaging for

amyloid and pathologic tau protein

Page 3: New Proteomics Strategies for Studying Alzheimer's and

So what do we need?

• We need methods that sample the same peptides in all samples

• We need methods where the change in signal reflects the change in quantity

• We need methods where we can get the same signal despite differences in sample preparation, instrument platform, etc…

• We need to recognize that changes can occur with individual peptides and not the overall gene product.

• We need a large sample size.

Page 4: New Proteomics Strategies for Studying Alzheimer's and

So what do we need?

• We need methods that sample the same peptides in all samples

• We need methods where the change in signal reflects the change in quantity

• We need methods where we can get the same signal despite differences in sample preparation, instrument platform, etc…

• We need to recognize that changes can occur with individual peptides and not the overall gene product.

• We need a large sample size.

Page 5: New Proteomics Strategies for Studying Alzheimer's and

Mass Spectrometry Data Acquisition Strategies Used in Proteomics

Data Dependent Acquisition (DDA)

Peptide Identification

NLPFSVENK

Database Searching

Condition 1 Condition 2 Condition 3 Condition 4Peptide 1Peptide 2Peptide 3Peptide 4Peptide 5Peptide 6Peptide 7Peptide 8Peptide 9Peptide 10Peptide 11Peptide 12Peptide 13Peptide 14Peptide 15Peptide 16Peptide 17Peptide 18Peptide 19Peptide 20Peptide 21Peptide 22Peptide 23Peptide 24Peptide 25Peptide 26Peptide 27Peptide 28Peptide 29Peptide 30

Page 6: New Proteomics Strategies for Studying Alzheimer's and

Mass Spectrometry Data Acquisition Strategies Used in Proteomics

Data Dependent Acquisition (DDA)

Peptide Identification

NLPFSVENK

Database Searching

Parallel Reaction Monitoring (PRM)

Peptide Quantification

NLPFSVENK

Targeted Analysis

Cycle time

Condition 1 Condition 2 Condition 3 Condition 4Peptide 1Peptide 2Peptide 3Peptide 4Peptide 5Peptide 6Peptide 7Peptide 8Peptide 9Peptide 10Peptide 11Peptide 12Peptide 13Peptide 14Peptide 15Peptide 16Peptide 17Peptide 18Peptide 19Peptide 20Peptide 21Peptide 22Peptide 23Peptide 24Peptide 25Peptide 26Peptide 27Peptide 28Peptide 29Peptide 30

Condition 1 Condition 2 Condition 3 Condition 4Peptide 1Peptide 2Peptide 3Peptide 4Peptide 5Peptide 6Peptide 7Peptide 8Peptide 9Peptide 10

Page 7: New Proteomics Strategies for Studying Alzheimer's and

Mass Spectrometry Data Acquisition Strategies Used in Proteomics

Data Dependent Acquisition (DDA)

Peptide Identification

NLPFSVENK

Database Searching

Parallel Reaction Monitoring (PRM)

Peptide Quantification

NLPFSVENK

Targeted Analysis

Cycle time

Data Independent Acquisition (DIA)

NLPFSVENK NLPFSVENK

Cycle time

~50 Hz• 4 m/z isolation (2 m/z

effective)• 500-900 m/z • 2 s Cycle Time

Condition 1 Condition 2 Condition 3 Condition 4Peptide 1Peptide 2Peptide 3Peptide 4Peptide 5Peptide 6Peptide 7Peptide 8Peptide 9Peptide 10Peptide 11Peptide 12Peptide 13Peptide 14Peptide 15Peptide 16Peptide 17Peptide 18Peptide 19Peptide 20Peptide 21Peptide 22Peptide 23Peptide 24Peptide 25Peptide 26Peptide 27Peptide 28Peptide 29Peptide 30

Condition 1 Condition 2 Condition 3 Condition 4Peptide 1Peptide 2Peptide 3Peptide 4Peptide 5Peptide 6Peptide 7Peptide 8Peptide 9Peptide 10

Condition 1 Condition 2 Condition 3 Condition 4Peptide 1Peptide 2Peptide 3Peptide 4Peptide 5Peptide 6Peptide 7Peptide 8Peptide 9Peptide 10Peptide 11Peptide 12Peptide 13Peptide 14Peptide 15Peptide 16Peptide 17Peptide 18Peptide 19Peptide 20Peptide 21Peptide 22Peptide 23Peptide 24Peptide 25Peptide 26Peptide 27Peptide 28Peptide 29Peptide 30

Page 8: New Proteomics Strategies for Studying Alzheimer's and

Improving Precursor Selectivity

Page 9: New Proteomics Strategies for Studying Alzheimer's and

Improving Precursor Selectivity

Amodei et al JASMS 2019

Page 10: New Proteomics Strategies for Studying Alzheimer's and

20 m/z DIA

GVMNAVNNVNNVIAAAFVK

Page 11: New Proteomics Strategies for Studying Alzheimer's and

20 m/z DIA + Overlap

GVMNAVNNVNNVIAAAFVK

Page 12: New Proteomics Strategies for Studying Alzheimer's and

20 m/z DIA + Overlap + Demultiplexing

GVMNAVNNVNNVIAAAFVK

Page 13: New Proteomics Strategies for Studying Alzheimer's and

10 m/z DIA

GVMNAVNNVNNVIAAAFVK

Page 14: New Proteomics Strategies for Studying Alzheimer's and

Separating Detection from Quantitation

24 m/z overlapping12 m/z effective

4 m/z overlapping2 m/z effective

Searle et al, Nature Comm, 2018

Page 15: New Proteomics Strategies for Studying Alzheimer's and

So what do we need?

• We need methods that sample the same peptides in all samples

• We need methods where the change in signal reflects the change in quantity

• We need methods where we can get the same signal despite differences in sample preparation, instrument platform, etc…

• We need to recognize that changes can occur with individual peptides and not the overall gene product.

• We need a large sample size.

Page 16: New Proteomics Strategies for Studying Alzheimer's and

Are the Measurements Quantitative or Differential?

Can we define LOQ and LOD for many peptides at once?

Page 17: New Proteomics Strategies for Studying Alzheimer's and

Assessment of LOD and LOQ

Building on:Galitzine C et al, MCP 2018

Page 18: New Proteomics Strategies for Studying Alzheimer's and

Matched Matrix Dilution Curves

Building on:Grant and Hoofnagle, Clin Chem 2014

Page 19: New Proteomics Strategies for Studying Alzheimer's and

Not all Peptides are Equal Quantitative Proxies for a Protein

Page 20: New Proteomics Strategies for Studying Alzheimer's and

Not all Peptides are Quantitative

• Detectable Peptides• Quantitative Peptides

Page 21: New Proteomics Strategies for Studying Alzheimer's and

So what do we need?

• We need methods that sample the same peptides in all samples

• We need methods where the change in signal reflects the change in quantity

• We need methods where we can get the same signal despite differences in sample preparation, instrument platform, etc…

• We need to recognize that changes can occur with individual peptides and not the overall gene product.

• We need a large sample size.

Page 22: New Proteomics Strategies for Studying Alzheimer's and

Comparing Signal Intensities Between Labs, Instrument PlatformsSignal Calibration in Proteomics?

Page 23: New Proteomics Strategies for Studying Alzheimer's and

Peak area measurements should scale with the amount of peptide in the sample

23

known quantity

Page 24: New Proteomics Strategies for Studying Alzheimer's and

Measurements on different platforms are not measured on the same scale

24

Page 25: New Proteomics Strategies for Studying Alzheimer's and

Between Batch/Platform/Lab Signal Calibration

Purpose of signal calibration

• Placing signal on the same scale

• Often the scale is arbitraryo Kilogram = mass of a liter of water at freezing pointo Meter = 1/10,000,000 the distance from the equator to the

north poleo Pee dee belomnite (PDB) = reference for 13C, fossil found in

Peedee Formation in South Carolinao Standard mean ocean water (SMOW) = reference for 18O,

arbitrary mix of distilled water from different regions of the world.

Page 26: New Proteomics Strategies for Studying Alzheimer's and

Data harmonization between days, instrument platforms, and laboratories

experimental

reference(control)

(osmotic shock)

yeast

BY4741Ghaemmaghami et alNature 2003

Pino et al, Anal Chem, 2018

Page 27: New Proteomics Strategies for Studying Alzheimer's and

Aliquots of reference material are prepared together with each experimental batch

Reference material aliquots

Experimental samples

Pino et al, Anal Chem, 2018

Page 28: New Proteomics Strategies for Studying Alzheimer's and

Data harmonization between days, instrument platforms, and laboratories

between daysbetween instrument platforms

between laboratories

Pino et al, Anal Chem, 2018

Page 29: New Proteomics Strategies for Studying Alzheimer's and

Signals measured on different platforms are often on different scales

between instrument platforms

Pino et al, Anal Chem, 2018

Page 30: New Proteomics Strategies for Studying Alzheimer's and

External reference calibration places different platforms on the same scale

30

between instrument platforms

Pino et al, Anal Chem, 2018

Page 31: New Proteomics Strategies for Studying Alzheimer's and

Calibration to the same reference minimizes quantitative variance

Pino et al, Anal Chem, 2018

Page 32: New Proteomics Strategies for Studying Alzheimer's and

Calibration to the same reference minimizes quantitative variance

Pino et al, Anal Chem, 2018

Page 33: New Proteomics Strategies for Studying Alzheimer's and

Calibration to the same reference minimizes quantitative variance

33

Page 34: New Proteomics Strategies for Studying Alzheimer's and

Calibration to the same reference minimizes quantitative variance

34

Pino et al, Anal Chem, 2018

Page 35: New Proteomics Strategies for Studying Alzheimer's and

So what do we need?

• We need methods that sample the same peptides in all samples

• We need methods where the change in signal reflects the change in quantity

• We need methods where we can get the same signal despite differences in sample preparation, instrument platform, etc…

• We need to recognize that changes can occur with individual peptides and not the overall gene product.

• We need a large sample size.

Page 36: New Proteomics Strategies for Studying Alzheimer's and

Different Peptides Reflect Different ProteoformsAmyloid Precursor Protein

Page 37: New Proteomics Strategies for Studying Alzheimer's and

Different Peptides Reflect Different Proteoforms7

Tau

Page 38: New Proteomics Strategies for Studying Alzheimer's and

So what do we need?

• We need methods that sample the same peptides in all samples

• We need methods where the change in signal reflects the change in quantity

• We need methods where we can get the same signal despite differences in sample preparation, instrument platform, etc…

• We need to recognize that changes can occur with individual peptides and not the overall gene product.

• We need a large sample size.

Page 39: New Proteomics Strategies for Studying Alzheimer's and

Shift from a Triangular Process to a Rectangular

Number of Samples

Discovery

Number of Samples

Validation

Discovery

Validation

Page 40: New Proteomics Strategies for Studying Alzheimer's and

Shift from a Triangular Process to a Rectangular

Number of Samples

Discovery

Number of Samples

Validation

Discovery

Validation

Page 41: New Proteomics Strategies for Studying Alzheimer's and

Measuring More Analytes Requires Measuring More Samples

Lazzeroni and Ray Mol Psychiatry. 2012 Jan; 17(1): 108–114.

Page 42: New Proteomics Strategies for Studying Alzheimer's and

Conclusions• Data independent acquisition offers systematic sampling over

traditional discovery proteomics.

• We have the ability to perform DIA with selectivity of 50% the precursor isolation window size across the entire m/z range.

• Dynamic range and sensitivity that approximates PRM but is comprehensive

• Signal can be calibrated between labs and instrument platforms using a common external reference sample

• Stop doing protein roll up for bottom-up proteomics.

• Proteomics assays that measure lots of peptides require lots of samples.

Page 43: New Proteomics Strategies for Studying Alzheimer's and

Financial SupportNIGMS BTRR P41 ProgramNIH Common Fund – LINCS ProgramNIA Nathan Shock CenterNIA Investigator Initiated R01 and P01NIGMS Investigator Initiated R01sIARPA Program

University of WashingtonDepartment of Genome SciencesBill NobleJohn StamatoyannopolousJudit Villen and Lab

The Broad InstituteJake Jaffe and Lab

UW Lab MedicineAndy Hoofnagle

NortheasternOlga Vitek and Lab

Former Lab MembersJarrett EgertsonBrian SearleSandi SpencerSonia Ting

University of WashingtonMacCoss LabJosh AldrichNat BraceBrian ConnollyDanielle FaivreAlex FederationAustin KellerEric HuangRich JohnsonBrendan MacLeanGennifer MerrihewBrook NunnLindsay PinoDeanna PlubellBrian PrattPaul RudnickVagisha SharmaNick ShulmanEmma Timmins-Schiffman

Stanford Tom Montine

ThermoFisherMary BlackburnRomain HuguetAndreas KuehnPhil RemesMike SenkoYue XuanVlad Zabrouskov

Acknowledgement

Software Vendor SupportAgilent ShimadzuBruker ThermoFisherSciex Waters

Page 44: New Proteomics Strategies for Studying Alzheimer's and

MacCoss Lab UW